A 30,000 sq ft sterile manufacturing facility at MEPZ-SEZ Tambaram, Chennai — designed end-to-end for biosimilar fill-finish across vials, pre-filled syringes and cartridges.
3 min 37 sec · MEPZ-SEZ, Chennai
Grade A/B cleanrooms per ISO 14644-1 with isolator-based filling under EU GMP Annex 1. Continuous viable and non-viable particulate monitoring across classified zones.
50 L and 350 L jacketed SS316L process vessels with magnetic-coupled and low-shear vibro-mixer drives for sensitive proteins. WFI loop and pure-steam at point of use.
3 mL, 5 mL and 10 mL Type I borosilicate vials — automated bromobutyl stoppering and aluminum flip-off crimping on the combi line for insulins and biosimilars.
20 / 40 / 60 / 80 mg PFS lines for enoxaparin — automated vacuum stoppering, plunger placement and in-line visual inspection per USP <790> for particulate matter.
3 mL insulin and GLP-1 cartridges on a combi line with rapid SKU changeover between vial, PFS and cartridge. CIP/SIP cycles validated per ISPE Baseline Guide.
Automated and semi-automated inspection stations — particulate, cosmetic defect and fill-volume verification per USP <790> and <1790> before secondary packaging.
HPLC, GC and Karl Fischer for chemistry; sterility (USP <71>), bacterial endotoxin (USP <85>), particulate matter (USP <788>) and container-closure integrity testing for microbiology.
Validated 2°C–8°C chain from finished-goods cold rooms through international air-freight. Real-time temperature logging and qualified shippers per WHO TRS 961 Annex 9.
Distributors, licensing partners and regulatory teams welcome on-site or via virtual walkthrough. Drop us a note — we'll arrange a date that works.